Humacyte, Inc. (HUMA) Misses Q3 EPS by 8c

Humacyte, Inc. (NASDAQ: HUMA) reported Q3 EPS of ($0.33), $0.08 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Regency Centers (REG) Tops Q2 EPS by 2c
• Kotak Downgrades Dixon Technologies India Ltd (DIXON:IN) to Add (2)
• Ferguson Enterprises to Join S&P 500; ADI Global Distribution to Join S&P SmallCap 600